Cargando…
Multiagonist Unimolecular Peptides for Obesity and Type 2 Diabetes: Current Advances and Future Directions
The ever-increasing prevalence of obesity and Type 2 diabetes has necessitated the development of newer and more effective approaches for achieving efficient glycemic control and weight loss. Conventional treatment methods often result in weight gain, further deteriorating the already impaired metab...
Autor principal: | Hasib, Annie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025423/ https://www.ncbi.nlm.nih.gov/pubmed/32110131 http://dx.doi.org/10.1177/1179551420905844 |
Ejemplares similares
-
Premises for Cholecystokinin and Gastrin Peptides in Diabetes Therapy
por: Rehfeld, Jens F
Publicado: (2019) -
Nonclassical Islet Peptides: Pancreatic and Extrapancreatic Actions
por: English, Andrew, et al.
Publicado: (2019) -
Characterisation of Glucose-Dependent Insulinotropic Polypeptide
Receptor Antagonists in Rodent Pancreatic Beta Cells and Mice
por: Perry, RA, et al.
Publicado: (2019) -
Dipeptidyl Peptidase-4 at the Interface Between Inflammation and Metabolism
por: Trzaskalski, Natasha A, et al.
Publicado: (2020) -
Activation of GPR40 as a Therapeutic Target for the Treatment of Type 2 Diabetes
por: Burant, Charles F.
Publicado: (2013)